Showing 411-420 of 7581 results for "".
DermWireTV: AbbVie to Acquire Allergan, Duobrii Launches, SDPA at 25
https://practicaldermatology.com/topics/psoriasis/dermwiretv-abbvie-to-acquire-allergan-duobrii-launches-sdpa-at-25/19629/In a deal with an equity value of approximately $63 billion, AbbVie has agreed to acquire Allergan. The new company is positioned for new growth platforms and a diversified revenue base; the deal will be immediately accretive to earnings per share, AbbVie says. The Society of Dermatology Physician AThe Advisor Advantage
https://practicaldermatology.com/topics/practice-management/the-advisor-advantage/23025/Seven benefits your advisor should bring to your portfolio.Effective Communication: Achieve Results You Want
https://practicaldermatology.com/topics/practice-management/effective-communication-achieve-results-you-want/19593/Kalyani Marathe, MD describes the Path to Action plan that can help you improve your communication skills—whether you're presenting, consulting with colleagues, or talking to patients. She offers tips for assessing your skills and finding ways to change your approach when needed.What Your Patients Need to Hear About Sunscreens
https://practicaldermatology.com/topics/general-topics/what-your-patients-need-to-hear-about-sunscreens/20432/You can't fight every misperception, but you can arm patients with essential facts.Painless, Non-Invasive Treatment for Non-melanoma Skin Cancer Offers Patients a Convenient Alternative
https://practicaldermatology.com/topics/general-topics/painless-non-invasive-treatment-for-non-melanoma-skin-cancer-offers-patients-a-convenient-alternative/20626/In recent years, an increasing number of clinicians and patients have opted for treatment with an advanced form of radiation called electronic brachytherapy (eBx).All in One
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/all-in-one/18726/The Sciton Joule platform offers multiple treatment options to address multiple indications in a single, scalable system, making it a top laser platform pick for 2017, says Dr. Cohen during Cosmetic Surgery Forum.Pico Pick-up: Expanding Applications
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/pico-pick-up-expanding-applications/18555/What started as a revolutionary approach to removing tattoos, is finding new applications for facial rejuvenation. The expanding use of picosecond technology is making the investment more attractive for aesthetically-focused practices, notes Dr. Gold.Do I Really Need an Investment Advisor?
https://practicaldermatology.com/topics/practice-management/do-i-really-need-an-investment-advisor/20866/Nine reasons physician-investors underperform without professional investment advice.Differin Goes OTC, ISDIN Comes to America, Understand AD
https://practicaldermatology.com/topics/psoriasis/dermwiretv-differin-goes-otc-isdin-comes-to-america-understand-ad/18762/Barcelona-based ISDIN is officially operating in the US. The company—which operates in Europe, Latin America, and Asia—is bringing its skincare products to the US market. Regeneron Pharmaceuticals, Sanofi Genzyme, the National Eczema Association, and the Dermatology Nurses Association launch UnderVanquish Approved for Circumferential Fat Reduction; Acquisition News
https://practicaldermatology.com/topics/skin-cancer-photoprotection/dermwiretv-vanquish-approved-for-circumferential-fat-reduction-acquisition-news/18884/BTL's Vanquish Cleared for Circumferential Fat Reduction of the Abdomen, Filler Injections Gain Popularity Off the Face, Protein Linked to Aggressive Melanomas, and new acquisitions at Kythera, Lumenis, XTRAC.